Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · IEX Real-Time Price · USD
8.67
-0.22 (-2.47%)
At close: May 31, 2024, 4:00 PM
8.77
+0.10 (1.15%)
After-hours: May 31, 2024, 6:22 PM EDT

MRVI Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019 2018
Cash & Equivalents
574.96632.14551.27236.1824.7
Upgrade
Cash & Cash Equivalents
574.96632.14551.27236.1824.7
Upgrade
Cash Growth
-9.04%14.67%133.41%856.21%12.96%
Upgrade
Receivables
54.61138.62117.5151.0218.03
Upgrade
Inventory
51.443.1551.5633.314.2
Upgrade
Other Current Assets
18.9533.9919.711.13.62
Upgrade
Total Current Assets
699.91847.9740.04331.660.55
Upgrade
Property, Plant & Equipment
162.952.6946.33101.3194.31
Upgrade
Goodwill and Intangibles
547.02500.33270.34401.93422.13
Upgrade
Other Long-Term Assets
77.62881.39861.57435.860.81
Upgrade
Total Long-Term Assets
787.541,4341,178939.09517.24
Upgrade
Total Assets
1,4872,2821,9181,271577.8
Upgrade
Accounts Payable
10.735.998.158.177.48
Upgrade
Deferred Revenue
3.363.0910.2178.060.84
Upgrade
Current Debt
6.075.44662.5
Upgrade
Other Current Liabilities
67.3195.6369.4138.5518.74
Upgrade
Total Current Liabilities
87.47110.1493.78130.7829.56
Upgrade
Long-Term Debt
550.6522524.59584.78387.7
Upgrade
Other Long-Term Liabilities
59.49744.93754.55400.3915.91
Upgrade
Total Long-Term Liabilities
610.11,2671,279985.17403.61
Upgrade
Total Liabilities
697.571,3771,3731,116433.17
Upgrade
Total Debt
556.68527.44530.59590.78390.2
Upgrade
Debt Growth
5.54%-0.59%-10.19%51.40%14.80%
Upgrade
Retained Earnings
285.74404.77184.560.85-42.38
Upgrade
Comprehensive Income
000-0.04-0.13
Upgrade
Shareholders' Equity
416.75545.22315.588.51141.4
Upgrade
Net Cash / Debt
18.29104.720.68-354.6-365.5
Upgrade
Net Cash / Debt Growth
-82.54%406.27%---
Upgrade
Net Cash Per Share
0.140.410.08-12.27-1.44
Upgrade
Working Capital
612.44737.76646.26200.8230.99
Upgrade
Book Value Per Share
3.164.142.758.550.56
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).